The store will not work correctly when cookies are disabled.
2-chloro-4-(3-(3,5-difluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide
ID: ALA3972337
PubChem CID: 18385960
Max Phase: Preclinical
Molecular Formula: C18H14ClF2NO4S
Molecular Weight: 413.83
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(C)OC(c2ccc(S(N)(=O)=O)c(Cl)c2)=C(c2cc(F)cc(F)c2)C1=O
Standard InChI: InChI=1S/C18H14ClF2NO4S/c1-18(2)17(23)15(10-5-11(20)8-12(21)6-10)16(26-18)9-3-4-14(13(19)7-9)27(22,24)25/h3-8H,1-2H3,(H2,22,24,25)
Standard InChI Key: IZMPQYNNFCONDJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
23.5789 -13.4424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1744 -12.7366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7654 -13.4398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8642 -8.0328 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8260 -8.8529 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.5553 -8.4759 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5138 -12.2610 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.8372 -12.2548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5797 -11.4766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7634 -11.4842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6151 -12.5051 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.2802 -10.8271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6095 -10.0780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1258 -9.4203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3127 -9.5105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9857 -10.2640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4715 -10.9186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0521 -10.8147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8664 -10.8956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3417 -10.2318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0039 -9.4867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1861 -9.4095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7144 -10.0742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0153 -8.9446 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4538 -8.6718 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
26.1550 -10.3116 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.8456 -8.6666 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
5 4 2 0
6 5 2 0
7 2 1 0
2 8 1 0
8 9 1 0
9 10 2 0
10 7 1 0
8 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
9 18 1 0
15 5 1 0
5 24 1 0
14 25 1 0
20 26 1 0
22 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 413.83 | Molecular Weight (Monoisotopic): 413.0300 | AlogP: 3.51 | #Rotatable Bonds: 3 |
Polar Surface Area: 86.46 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.01 | CX Basic pKa: ┄ | CX LogP: 3.69 | CX LogD: 3.68 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.83 | Np Likeness Score: -0.44 |
References
1. (2002) 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors, |